<DOC>
	<DOC>NCT02367820</DOC>
	<brief_summary>The purpose of this 52-week open label study is to determine the safety of a new opioid molecule, NKTR-181, in patients with moderate to severe chronic low back pain or chronic non-cancer pain.</brief_summary>
	<brief_title>Long-Term Safety and Tolerability Study of NKTR-181 in Subjects With Chronic Low Back Pain or Chronic Non-Cancer Pain</brief_title>
	<detailed_description>This is an open-label safety and tolerability study in which approximately 600 subjects will receive NKTR-181 for up to 52 weeks. Subjects may include newly enrolled subjects and subjects who have recently completed SUMMIT-07 or SUMMIT-12 studies. This study will also investigate the pharmacokinetics of NKTR-181 in patients with chronic low back pain or chronic non-cancer pain.</detailed_description>
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<criteria>Male or nonpregnant, nonnursing female aged 18 to 75 years old Clinical diagnosis of moderate to severe, chronic low back or noncancer pain for at least three months Not experiencing adequate pain relief or have failed previous treatment with nonopioid analgesics Opioid analgesia is necessary Currently taking no more than 60 mg morphine sulfate equivalents per day of opioid analgesics for at least 7 days prior to entry Females of child bearing potential must be using a highly effective form of birth control. All subjects must agree to use doublebarrier contraception during participation in this study and for at least 2 months after the last dose of the study drug. Willing and able to provide informed consent History of hypersensitivity, intolerance, or allergy to opioids Surgical procedures in the last 4 weeks or plans to undergo surgical procedures during the study period Untreated moderate to severe sleep apnea Chronic migraines as the primary pain condition Cancer related pain</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>